Relapse prevention group-work: a clinical evaluation

Author： Bliss Paul   Murphy Kevin   Ricketts Tom  

Publisher： Radcliffe Press

ISSN： 1465-9891

Source： Journal of Substance Use, Vol.7, Iss.2, 2002-06, pp. : 78-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapeutic approaches in relapse prevention

By Chick J.D.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 194-194

Elsevier

Access to resources Recommend Favorite

The Cost Effectiveness of Acamprosate in the Treatment of Alcoholism in Germany: Economic Evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study

By Schädlich P.K.   Brecht J.G.  

PharmacoEconomics, Vol. 13, Iss. 6, 1998-06 ,pp. : 719-730

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Schizophrenia Relapse Prevention: An Economic Evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) Study in Spain

By Bernardo Miguel  

Clinical Drug Investigation, Vol. 26, Iss. 8, 2006-01 ,pp. : 447-457

Adis International

Access to resources Recommend Favorite

Relapse Prevention in Alcoholics: A Review of Acamprosate versus Naltrexone

By Hoes M.J.A.J.M.  

Clinical Drug Investigation, Vol. 17, Iss. 3, 1999-03 ,pp. : 211-216

Adis International

Access to resources Recommend Favorite

Shocking results for drugs, ECT in depression relapse prevention

By  

Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite